全文获取类型
收费全文 | 27280篇 |
免费 | 1780篇 |
国内免费 | 48篇 |
专业分类
耳鼻咽喉 | 306篇 |
儿科学 | 927篇 |
妇产科学 | 871篇 |
基础医学 | 3373篇 |
口腔科学 | 332篇 |
临床医学 | 4165篇 |
内科学 | 4904篇 |
皮肤病学 | 306篇 |
神经病学 | 2717篇 |
特种医学 | 652篇 |
外科学 | 2306篇 |
综合类 | 285篇 |
一般理论 | 65篇 |
预防医学 | 3830篇 |
眼科学 | 347篇 |
药学 | 1607篇 |
1篇 | |
中国医学 | 26篇 |
肿瘤学 | 2088篇 |
出版年
2023年 | 102篇 |
2022年 | 171篇 |
2021年 | 463篇 |
2020年 | 307篇 |
2019年 | 488篇 |
2018年 | 591篇 |
2017年 | 462篇 |
2016年 | 486篇 |
2015年 | 536篇 |
2014年 | 813篇 |
2013年 | 1312篇 |
2012年 | 1886篇 |
2011年 | 1942篇 |
2010年 | 1056篇 |
2009年 | 937篇 |
2008年 | 1792篇 |
2007年 | 1932篇 |
2006年 | 1905篇 |
2005年 | 1937篇 |
2004年 | 1849篇 |
2003年 | 1750篇 |
2002年 | 1624篇 |
2001年 | 264篇 |
2000年 | 204篇 |
1999年 | 294篇 |
1998年 | 371篇 |
1997年 | 264篇 |
1996年 | 261篇 |
1995年 | 237篇 |
1994年 | 201篇 |
1993年 | 199篇 |
1992年 | 152篇 |
1991年 | 130篇 |
1990年 | 120篇 |
1989年 | 127篇 |
1988年 | 110篇 |
1987年 | 111篇 |
1986年 | 110篇 |
1985年 | 121篇 |
1984年 | 142篇 |
1983年 | 131篇 |
1982年 | 152篇 |
1981年 | 136篇 |
1980年 | 129篇 |
1979年 | 79篇 |
1978年 | 86篇 |
1977年 | 86篇 |
1976年 | 61篇 |
1975年 | 77篇 |
1974年 | 57篇 |
排序方式: 共有10000条查询结果,搜索用时 10 毫秒
1.
Severe persistent asthma can have a substantial impact on a patient's health-related quality of life (HRQL), both as a result of symptoms and from side effects of treatment. The HRQL impact of two doses (400 and 800 microg twice daily) of mometasone furoate dry powder inhaler (MF DPI) was compared with placebo in patients with severe persistent asthma previously maintained on oral steroids as a component of a previously published randomized, 12-week, double-blind, placebo-controlled, multicenter trial. A 9-month open-label extension (OLE), with all patients treated with MF DPI, followed. Patients 12 years of age or older completed a generic HRQL measure, the Medical Outcomes Trust Short Form-36 (SF-36), and an asthma-specific measure, the Marks Asthma Quality of Life Questionnaire (AQLQ-M), at baseline, at endpoint (last evaluable visit) of the double-blind phase (EODBP), and after the first 3 months of the OLE. Of 132 patients enrolled in the study, 128 provided HRQL data at baseline and at EODBP. Mean SF-36 scores at baseline showed significant HRQL impairment compared with U.S. general population norms. With treatment, the reduction in oral corticosteroid (OCS) requirements of the MF-DPI-treated groups was accompanied by significant (p < 0.05) improvement over placebo in the physical domain of HRQL (SF-36 physical component summary score and the physical function subscale) at EODBP. MF-DPI-treated patients also showed significant improvements at EODBP in each of the four subscales of the AQLQ-M (p<0.05). From EODBP to the OLE 3-month endpoint, patients treated with MF DPI twice daily maintained, or improved, SF-36 scores in most domains. Symptomatic improvement and reduction in OCS use with MF DPI were accompanied by significant improvement in HRQL in patients with severe persistent asthma. These improvements were maintained during the 3-month period of the OLE in which HRQL was evaluated. 相似文献
2.
Tony R Cucuzzella Elva G Delport Nancy Kim Julie Marley Christine Pruitt Anton G Delport 《The spine journal》2006,6(4):364-369
BACKGROUND CONTEXT: Substantial variation exists regarding the use of sedation before interventional spine techniques. Patient preference should play an important role in decision making regarding the need for sedation. However, little is known about patients' anxiety levels before spinal injections and their perceptions about the necessity of sedation. PURPOSE: To determine patient perception for need for sedation before epidural steroid injections and zygapophyseal joint injections. STUDY DESIGN/SETTING: Survey of consecutive spinal injection patients in an outpatient spine center. PATIENT SAMPLE: 500 consecutive lumbar, thoracic, and cervical patients receiving spinal injections. OUTCOME MEASURES: A 12-item questionnaire assessing patients' perceived anxiety before to a spinal injection. METHODS: Subjects were given the questionnaire after their spinal injection. Percentages requesting sedation for a first and potential second procedure were assessed. Additionally, anxiety level and pain rating, location of injection, age, sex, and other medication use were analyzed to determine the effect on the request for sedation. RESULTS: 17% of patients questioned requested sedation before an injection, and 28% would request sedation if they were to have a second injection. CONCLUSIONS: Routine sedation before diagnostic and therapeutic injections is not necessary as the majority of patients would not request sedation before the procedure when given the option. However, in some patients sedation is indicated, and all patients would benefit from educational material on sedation before the injection. 相似文献
3.
4.
5.
Nancy L. Snyderman 《The Laryngoscope》1987,97(3):353-356
Trichinosis is a rare cause of a neck mass, but should be considered by the physician when contemplating a differential diagnosis. This disease is still endemic in parts of the world and is directly related to the ingestion of incompletely cooked pork. A case is presented in which a 68-year-old man was diagnosed as having a squamous cell carcinoma of the mandible only to have trichinosis diagnosed on the final pathologic report. The case presentation is followed by a historical review and discussion. 相似文献
6.
7.
8.
Background
The mitogen-activated protein kinases, MAPKs for short, constitute cascades of signalling pathways involved in the regulation of several cellular processes that include cell proliferation, differentiation and motility. They also intervene in neurological processes like fear conditioning and memory. Since little remains known about the MAPK-Activated Protein Kinase, MAPKAPK5, we constructed the first MAPKAPK knockin mouse model, using a constitutive active variant of MAPKAPK5 and analyzed the resulting mice for changes in anxiety-related behaviour. 相似文献9.
Dietmar Winkler Matth?us Willeit Rainer Wolf Mara Stamenkovic Johannes Tauscher Edda Pjrek Anastasios Konstantinidis Shird Schindler Christian Barnas Siegfried Kasper 《European neuropsychopharmacology》2003,13(2):129-134
The value of a long-term treatment with clonazepam in the prophylaxis of affective disorder is discussed controversially in the scientific literature. Altogether there are only a few reports on the use of this compound as a mood stabilizer, most of them describing patients suffering from bipolar affective disorder. The aim of this investigation was to evaluate clonazepam as a phase prophylactic medication in affective disorder. We conducted a retrospective chart review in 34 out-patients of our lithium clinic (15 suffering from unipolar depression, 15 from bipolar disorder, four from schizoaffective disorder), who had been treated with clonazepam as a long-term medication. Clonazepam was either given as monotherapy, or as in the case of lithium non-responders, as adjunctive therapy. Patients with unipolar depression had significantly (P=0.026) less depressive episodes after initiation of treatment with clonazepam. Patients with bipolar disorder did not benefit from this therapy. Neither manic/hypomanic phases nor depressive episodes were reduced in this group of patients. Interestingly, clonazepam also reduced affective phases in our four schizoaffective patients on a trend level. Our results indicate that patients with unipolar depression may benefit from a maintenance treatment with clonazepam. Due to methodological limitations our results need to be replicated in controlled double-blind randomized clinical trials. 相似文献
10.